ALKERMES INC
10-K405, EX-27, 2000-06-29
PHARMACEUTICAL PREPARATIONS
Previous: ALKERMES INC, 10-K405, EX-23, 2000-06-29
Next: INTEGRATED CIRCUIT SYSTEMS INC, S-8, 2000-06-29



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 10-K FOR
THE YEAR ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           6,101
<SECURITIES>                                   331,267
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               345,841
<PP&E>                                          53,424
<DEPRECIATION>                                (20,554)
<TOTAL-ASSETS>                                 413,961
<CURRENT-LIABILITIES>                           22,487
<BONDS>                                        222,792
                                0
                                         23
<COMMON>                                           540
<OTHER-SE>                                     167,404
<TOTAL-LIABILITY-AND-EQUITY>                   413,961
<SALES>                                              0
<TOTAL-REVENUES>                                22,920
<CGS>                                                0
<TOTAL-COSTS>                                   54,483
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,652
<INCOME-PRETAX>                               (68,047)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (68,047)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (68,047)
<EPS-BASIC>                                     (1.52)
<EPS-DILUTED>                                   (1.52)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission